Sex-dependent association between erythrocyte n-3 PUFA and type 2 diabetes in older overweight people

British Journal of Nutrition

Volumn 115, Issue 8, 2016, Pages 1379-1386

  Abbott, Kylie A ^a   Veysey, Martin ^b   Lucock, Mark ^c   Niblett, Suzanne ^b   King, Katrina ^b   Burrows, Tracy ^a   Garg, Manohar L ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Insulin resistance; n 3 Index; Obesity; PUFA; Type 2 diabetes

Indexed keywords

DOCOSAHEXAENOIC ACID; GLUCOSE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; INSULIN; OMEGA 3 FATTY ACID; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; AUSTRALIAN; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ERYTHROCYTE LEVEL; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; SEX DIFFERENCE; SUGAR INTAKE; VERY ELDERLY; WAIST CIRCUMFERENCE; AGE; ANALYSIS; AUSTRALIA; BLOOD; CHEMISTRY; DIET; ERYTHROCYTE; PHYSIOLOGY; SEX FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRALIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; OVERWEIGHT; SEX FACTORS;

EID: 84958776721     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516000258     Document Type: Article

References (39)

1. Wild S, Roglic G, Green A, et al. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 27, 1047-1053.
2. Malekshahi Moghadam A, Saedisomeolia A, Djalali M, et al. (2012) Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Singapore Med J 53, 615-619.
3. Hartweg J, Perera R, Montori V, et al. (2008) Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev Issue 1. Art. No. CD003205.
4. Zhou Y, Tian C & Jia C (2012) Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies. Br J Nutr 108, 408-417.
5. Wallin A, Di Giuseppe D, Orsini N, et al. (2012) Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 35, 918-929.
6. Zhang M, Picard-Deland E & Marette A (2013) Fish and marine omega-3 polyunsaturated fatty acid consumption and incidence of type 2 diabetes: a systematic review and meta-analysis. Int J Endocrinol 2013, 501015.
7. Zheng JS, Huang T, Yang J, et al. (2012) Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLOS ONE 7, e44525.
8. Wu JH, Micha R, Imamura F, et al. (2012) Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 107, Suppl. 2, S214-S227.
9. Nkondjock A & Receveur O (2003) Fish-seafood consumption, obesity, and risk of type 2 diabetes: an ecological study. Diabetes Metab 29, 635-642.
10. Harris WS (2009) The omega-3 index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep 11, 411-417.
11. Burrows T, Collins CE & Garg ML (2011) Omega-3 index, obesity and insulin resistance in children. Int J Pediatr Obes 6, e532-e539.
12. Lassale C, Guilbert C, Keogh J, et al. (2009) Estimating food intakes in Australia: validation of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) food frequency questionnaire against weighed dietary intakes. J Hum Nutr Diet 22, 559-566.
13. Giles-Corti B, Timperio A, Cutt H, et al. (2006) Development of a reliable measure of walking within and outside the local neighbourhood: RESIDE's Neigbourhood Physical Activity Questionnaire. Prev Med 42, 455-459.
14. Craig C, Marshall A, Sjostrom M, et al. (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35, 1381-1395.
15. Australian Institute of Health and Welfare (2003) The Active Australia Survey: A Guide and Manual for Implementation, Analysis and Reporting. Canberra: Australian Institute of Health and Welfare.
16. Janssen I & Mark AE (2007) Elevated body mass index and mortality risk in the elderly. Obesity Rev 8, 41-59.
17. Lepage G & Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114-120.
18. Harris WS (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 55, 217-223.
19. World Health Organisation (2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Geneva: WHO Document Production Services.
20. Esteghamati A, Ashraf H, Esteghamati A-R, et al. (2009) Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance. Diabetes Res Clin Pract 84, 279-287.
21. Djousse L, Biggs ML, Lemaitre RN, et al. (2011) Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr 94, 527-533.
22. Takkunen MJ, Schwab US, de Mello VD, et al. (2015) Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr (epublication ahead of print version 1 May 2015).
23. Mahendran Y, Agren J, Uusitupa M, et al. (2014) Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr 99, 79-85.
24. Zhang G, Sun Q, Hu FB, et al. (2012) Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese. J Clin Endocrinol Metab 97, E973-E977.
25. Lauritzen L, Harslof LB, Hellgren LI, et al. (2012) Fish intake, erythrocyte n-3 fatty acid status and metabolic health in Danish adolescent girls and boys. Br J Nutr 107, 697-704.
26. Juarez-Lopez C, Klunder-Klunder M, Madrigal-Azcarate A, et al. (2013) Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents. Pediatr Diabetes 14, 377-383.
27. Rafraf M, Mohammadi E, Asghari-Jafarabadi M, et al. (2012) Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. J Am Coll Nutr 31, 361-368.
28. Crochemore IC, Souza AF, de Souza AC, et al. (2012) -3 Polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity. Nutr Clin Pract 27, 553-560.
29. Kelley DS, Adkins Y, Woodhouse LR, et al. (2012) Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men. Metab Syndr Relat Disord 10, 32-38.
30. Harris WS, Pottala JV, Varvel SA, et al. (2013) Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids 88, 257-263.
31. Kroger J, Zietemann V, Enzenbach C, et al. (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 93, 127-142.
32. Childs CE, Romeu-Nadal M, Burdge GC, et al. (2008) Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc 67, 19-27.
33. Phang M, Sinclair AJ, Lincz LF, et al. (2012) Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation. Nutr Metab Cardiovasc Dis 22, 109-114.
34. Phang M, Lincz LF & Garg ML (2013) Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women. J Nutr 143, 457-463.
35. O'Sullivan TA, Ambrosini GL, Mori TA, et al. (2011) Omega-3 index correlates with healthier food consumption in adolescents and with reduced cardiovascular disease risk factors in adolescent boys. Lipids 46, 59-67.
36. Colagiuri R, Girgis S, Gomez M, et al. (2009) National Evidence Based Guidelines for the Primary Prevention of Type 2 Diabetes. Canberra: National Health and Medical Research Council.
37. Kadowaki T, Yamauchi T, Kubota N, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792.
38. Gray B, Steyn F, Davies PS, et al. (2013) Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr 67, 1234-1242.
39. Grygiel-Gorniak B (2014) Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications-a review. Nutr J 13, 17.